Alexandre Arnaud

ORCID: 0000-0003-0919-780X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organoboron and organosilicon chemistry
  • Protein Kinase Regulation and GTPase Signaling
  • Antifungal resistance and susceptibility
  • Catalytic Cross-Coupling Reactions
  • Click Chemistry and Applications
  • Chemical synthesis and alkaloids
  • Pneumonia and Respiratory Infections
  • Chemical Synthesis and Reactions
  • Synthesis and biological activity
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Chronic Lymphocytic Leukemia Research
  • 14-3-3 protein interactions
  • Bacterial biofilms and quorum sensing
  • Sulfur-Based Synthesis Techniques
  • Signaling Pathways in Disease
  • Fungal Plant Pathogen Control
  • Cellular transport and secretion
  • Catalytic C–H Functionalization Methods
  • Microbial Metabolism and Applications
  • Synthesis and Biological Evaluation
  • Cystic Fibrosis Research Advances
  • Chronic Myeloid Leukemia Treatments
  • Antibiotic Resistance in Bacteria

Université Claude Bernard Lyon 1
2020-2024

Laboratoire de Chémo-biologie synthétique et thérapeutique
2021

Normandie Université
2018

Institut National des Sciences Appliquées Rouen Normandie
2018

Université de Rouen Normandie
2018

Laboratoire COBRA
2018

The nitrosation of indoles under slightly acidic conditions and reverse addition leads to the preparation corresponding indazole-3-carboxaldehydes in high yields greatly minimizes side reactions.

10.1039/c8ra01546e article EN cc-by RSC Advances 2018-01-01

A series of 4-membered sulfur-containing heterocycles was designed and evaluated for their ability to inhibit protein kinase DYRK1A, a target known have several potential therapeutic applications including cancers, Down syndrome or Alzheimer's disease.Our medicinal chemistry strategy relied on the design new compounds using ring contraction/isosteric replacement constrained analogy DYRK1A inhibitors, thus resulting in inhibitory activity enhancement.Whereas good effect targeted observed...

10.2139/ssrn.4830434 preprint EN 2024-01-01

A series of sulfur-containing tetracycles was designed and evaluated for their ability to inhibit protein kinase DYRK1A, a target known have several potential therapeutic applications including cancers, Down syndrome or Alzheimer's disease. Our medicinal chemistry strategy relied on the design new compounds using ring contraction/isosteric replacement constrained analogy DYRK1A inhibitors, thus resulting in inhibitory activity enhancement. Whereas good effect targeted observed 5-hydroxy 4i-k (IC

10.1039/d4md00537f article EN cc-by-nc RSC Medicinal Chemistry 2024-01-01

This data article is related to a research paper entitled "Solvent- and metal-free hydroboration of alkynes under microwave irradiation" (Gioia et al. TETL-D-19-01698) [1]. Herein we present the spectral acquired from synthesis (E)-alkenyl boronic acid pinacol esters. The include general information synthetic procedure affording target derivatives, which were fully characterized by Nuclear Magnetic Resonance (1H 13C NMR) and, for most part, Electrospray Ionization High Resolution Mass...

10.1016/j.dib.2020.105354 article EN cc-by-nc-nd Data in Brief 2020-03-03
Coming Soon ...